| Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial S Horwitz, OA O'Connor, B Pro, T Illidge, M Fanale, R Advani, NL Bartlett, ... The Lancet 393 (10168), 229-240, 2019 | 693 | 2019 |
| Genetic variants in C5 and poor response to eculizumab J Nishimura, M Yamamoto, S Hayashi, K Ohyashiki, K Ando, AL Brodsky, ... New England Journal of Medicine 370 (7), 632-639, 2014 | 433 | 2014 |
| Roles for c-Myc in self-renewal of hematopoietic stem cells Y Satoh, I Matsumura, H Tanaka, S Ezoe, H Sugahara, M Mizuki, ... Journal of Biological Chemistry 279 (24), 24986-24993, 2004 | 207 | 2004 |
| Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability C Mantel, Y Guo, MR Lee, MK Kim, MK Han, H Shibayama, S Fukuda, ... Blood 109 (10), 4518-4527, 2007 | 171 | 2007 |
| Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis H Shibayama, E Takai, I Matsumura, M Kouno, E Morii, Y Kitamura, ... The Journal of experimental medicine 199 (4), 581-592, 2004 | 155 | 2004 |
| Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent … H Daino, I Matsumura, K Takada, J Odajima, H Tanaka, S Ueda, ... Blood, The Journal of the American Society of Hematology 95 (8), 2577-2585, 2000 | 147 | 2000 |
| Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor–induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell … S Ueda, M Mizuki, H Ikeda, T Tsujimura, I Matsumura, K Nakano, H Daino, ... Blood, The Journal of the American Society of Hematology 99 (9), 3342-3349, 2002 | 137 | 2002 |
| Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse S Kurosawa, T Yamaguchi, S Miyawaki, N Uchida, T Sakura, H Kanamori, ... Haematologica 95 (11), 1857, 2010 | 133 | 2010 |
| Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1 E Ishiko, I Matsumura, S Ezoe, K Gale, J Ishiko, Y Satoh, H Tanaka, ... Journal of Biological Chemistry 280 (6), 4929-4939, 2005 | 128 | 2005 |
| Final 3-year results of the dasatinib discontinuation trial in patients with chronic myeloid leukemia who received dasatinib as a second-line treatment M Okada, J Imagawa, H Tanaka, H Nakamae, M Hino, K Murai, Y Ishida, ... Clinical Lymphoma Myeloma and Leukemia 18 (5), 353-360. e1, 2018 | 117 | 2018 |
| Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma MAA Zaki, N Wada, J Ikeda, H Shibayama, K Hashimoto, T Yamagami, ... Virchows Archiv 459, 361-366, 2011 | 115 | 2011 |
| Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era N Tomita, M Yokoyama, W Yamamoto, R Watanabe, Y Shimazu, Y Masaki, ... Cancer Science 103 (2), 245-251, 2012 | 106 | 2012 |
| Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial S Kimura, J Imagawa, K Murai, M Hino, T Kitawaki, M Okada, H Tanaka, ... The Lancet Haematology 7 (3), e218-e225, 2020 | 88 | 2020 |
| A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia N Sekiguchi, S Rai, W Munakata, K Suzuki, H Handa, H Shibayama, ... Cancer Science 111 (9), 3327-3337, 2020 | 71 | 2020 |
| Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma T Facon, CP Venner, NJ Bahlis, F Offner, DJ White, L Karlin, ... Blood, The Journal of the American Society of Hematology 137 (26), 3616-3628, 2021 | 69 | 2021 |
| Necessity of tyrosine 719 and phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine … K Hashimoto, I Matsumura, T Tsujimura, DK Kim, H Ogihara, H Ikeda, ... Blood, The Journal of the American Society of Hematology 101 (3), 1094-1102, 2003 | 65 | 2003 |
| AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells Y Satoh, I Matsumura, H Tanaka, S Ezoe, K Fukushima, M Tokunaga, ... Journal of biological chemistry 283 (44), 30045-30056, 2008 | 59 | 2008 |
| Pre‐and post‐serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation S Kusakabe, K Fukushima, T Maeda, D Motooka, S Nakamura, J Fujita, ... British Journal of Haematology 188 (3), 438-449, 2020 | 54 | 2020 |
| Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells X Zhang, T Machii, I Matsumura, S Ezoe, A Kawasaki, H Tanaka, S Ueda, ... International journal of hematology 77, 263-273, 2003 | 48 | 2003 |
| Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: a nationwide hospital‐based study Y Imaizumi, M Iwanaga, K Nosaka, K Ishitsuka, K Ishizawa, S Ito, ... Cancer Science 111 (12), 4567-4580, 2020 | 47 | 2020 |
